Cochrane · systematic review · CD012868
Fludrocortisone for orthostatic hypotension
Veazie, S, Peterson, K, Ansari, Y, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
NeuromuscularAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 3 · 50%Very low 3 · 50%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Fludrocortisone compared to placebo for people with diabetes and orthostatic hypotension
Population: people with diabetes and orthostatic hypotension
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Blood pressure outcomes Fludrocortisone vs placebo | no estimate extracted | 1 study · 6 participants | Very low Downgraded: risk of bias, imprecision |
Orthostatic symptoms Fludrocortisone vs placebo | no estimate extracted | 1 study · 6 participants | Very low Downgraded: risk of bias, imprecision |
Frequency and severity of postural lightheadedness Fludrocortisone vs placebo | no estimate extracted | 0 participants | Ungraded |
Frequency of syncope Fludrocortisone vs placebo | no estimate extracted | 0 participants | Ungraded |
Quality of life Fludrocortisone vs placebo | no estimate extracted | 0 participants | Ungraded |
Serious or severe adverse events Fludrocortisone vs placebo | no estimate extracted | 1 study · 6 participants | Very low Downgraded: risk of bias, imprecision |